MRK’s Januvia/Janumet franchise is now selling at a $4.2B annualized rate: http://finance.yahoo.com/news/Merck-Announces-First-Quarter-bw-3035206367.html?x=0&.v=1 The Januvia franchise has filled the hole from declining sales of Vytorin/Zetia in the past few years. Who said old-fashioned blockbusters are dead?